Detalles de la búsqueda
1.
Review of flow cytometry as a tool for cell and gene therapy.
Cytotherapy
; 26(2): 103-112, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37943204
2.
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.
Blood
; 136(25): 2905-2917, 2020 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33331927
3.
Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.
J Clin Immunol
; 41(6): 1146-1153, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33983545
4.
Identification of new cytokine combinations for antigen-specific T-cell therapy products via a high-throughput multi-parameter assay.
Cytotherapy
; 23(1): 65-76, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32921560
5.
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.
Br J Haematol
; 187(2): 206-218, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31219185
6.
Antiviral T Cells for Adenovirus in the Pretransplant Period: A Bridge Therapy for Severe Combined Immunodeficiency.
Biol Blood Marrow Transplant
; 24(9): 1944-1946, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753156
7.
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication.
Nat Commun
; 15(1): 2749, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38553461
8.
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
Nat Commun
; 15(1): 3258, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637498
9.
The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability.
J Exp Med
; 203(5): 1319-28, 2006 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16682499
10.
Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function.
Blood
; 115(17): 3498-507, 2010 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-20032499
11.
Regulating Treg cells at sites of inflammation.
Immunity
; 29(4): 511; author reply 512, 2008 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-18957259
12.
Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-ß.
Mol Ther Methods Clin Dev
; 27: 415-430, 2022 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36381305
13.
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products.
Mol Ther Methods Clin Dev
; 25: 439-447, 2022 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35506060
14.
Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte cultures.
Blood Transfus
; 19(6): 456-466, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34369863
15.
SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.
Front Immunol
; 12: 793197, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35116027
16.
Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.
J Immunol
; 181(5): 3039-48, 2008 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18713974
17.
T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1.
Front Immunol
; 11: 575977, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33123159
18.
High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy.
Clin Cancer Res
; 26(5): 1152-1161, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31615935
19.
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.
Cell Res
; 28(4): 416-432, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29472691
20.
An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth.
Blood Adv
; 1(15): 1107-1119, 2017 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29296753